| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 08/26/2004 | CA2516344A1 Tra16 a tr4/tr2 repressor |
| 08/26/2004 | CA2515941A1 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention |
| 08/26/2004 | CA2515676A1 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 08/26/2004 | CA2515638A1 Novel bicyclic compounds and compositions |
| 08/26/2004 | CA2515544A1 Compounds for the treatment of viral infection |
| 08/26/2004 | CA2515534A1 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 08/26/2004 | CA2515444A1 Immunoglobulin formulation and method of preparation thereof |
| 08/26/2004 | CA2515424A1 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions |
| 08/26/2004 | CA2515407A1 Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form |
| 08/26/2004 | CA2515368A1 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 08/26/2004 | CA2515292A1 Random and non-random alkylene oxide polymer alloy compositions |
| 08/26/2004 | CA2515214A1 Cosmetic compositions containing phenyl silicones |
| 08/26/2004 | CA2514912A1 Rnai targeting of viruses |
| 08/26/2004 | CA2514720A1 Coated particles and pharmaceutical dosage forms |
| 08/26/2004 | CA2514363A1 Substituted azole derivatives as therapeutic agents |
| 08/26/2004 | CA2513061A1 Hsp60 from arthrobacter |
| 08/26/2004 | CA2512989A1 Screening and treatment methods for prevention of preterm delivery |
| 08/26/2004 | CA2512934A1 Short immunomodulatory oligonucleotides |
| 08/26/2004 | CA2512589A1 Production of very long chain polyunsaturated fatty acids in oilseed plants |
| 08/26/2004 | CA2488143A1 Methods and compositions for modulating glutamate transport activity in the nervous system |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1449531A2 Melt-extruded orally administrable opioid formulations |
| 08/25/2004 | EP1449530A2 Melt-extruded orally administrable opioid formulations |
| 08/25/2004 | EP1449524A1 Methods and devices for providing prolonged drug therapy |
| 08/25/2004 | EP1449511A1 Use of Idebenone for the preservation of compositions |
| 08/25/2004 | EP1448800A2 Digital assay |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448523A1 Heterocyclic compounds and methods of use |
| 08/25/2004 | EP1448212A1 Mint extract pharmaceutical compositions |
| 08/25/2004 | EP1448205A2 Combinations for the treatment of immunoinflammatory disorders |
| 08/25/2004 | EP1448201A2 Use of n-(indolcarbonyl-)piperazine derivatives |
| 08/25/2004 | EP1448182A1 Pharmaceutical compositions and methods for administering ep 2 receptor selective agonists |
| 08/25/2004 | EP0969799B1 Oxidation dyeing composition for keratin fibres and dyeing method using said composition |
| 08/25/2004 | CN1163270C Modified meningococcal polysacharide conjugate vaccines |
| 08/24/2004 | US6780972 Reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger; forming a free peptide; and then forming the desired acid addition salt of the peptide |
| 08/24/2004 | US6780879 As antitumor agent |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/19/2004 | WO2004069291A2 Instrument for assisting in the remote placement of tied surgical knots and trimming of suture away from the knot and method of use |
| 08/19/2004 | WO2004069208A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069207A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069206A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069205A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069204A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069202A2 Antiglucocorticoids for the treatment of postpartum psychosis |
| 08/19/2004 | WO2004069201A2 Compounds useful in coating stents to prevent and treat stenosis and restenosis |
| 08/19/2004 | WO2004069200A2 Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
| 08/19/2004 | WO2004069199A2 Marketing system for improving patient compliance and methods and devices relating to same |
| 08/19/2004 | WO2004069196A2 Novel compounds |
| 08/19/2004 | WO2004069194A2 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes |
| 08/19/2004 | WO2004069193A2 Methods and compositions for inhibiting cholesterol uptake |
| 08/19/2004 | WO2004069191A2 Identification of t1r and t2r modulators |
| 08/19/2004 | WO2004069190A2 Combination therapy for treating protein deficiency disorders |
| 08/19/2004 | WO2004069189A2 Methods of assessment of drug metabolizing enzymes |
| 08/19/2004 | WO2004069184A2 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | WO2004069183A2 Immune regulation based on the targeting of early activation molecules |
| 08/19/2004 | WO2004069182A2 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | WO2004069181A2 Composition for the treatment of intraocular pressure |
| 08/19/2004 | WO2004069180A2 Solid dispersion compositions |
| 08/19/2004 | WO2004069179A2 Improved thickened beverages for dysphagia |
| 08/19/2004 | WO2004069178A2 Anti-inflammatory activity from lactic acid bacteria |
| 08/19/2004 | WO2004069177A2 Methods for modulating an inflammatory response |
| 08/19/2004 | WO2004069175A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON’S DISEASE AND OTHER α-SYNUCLEINOPATHIES |
| 08/19/2004 | WO2004069174A2 Monitoring and treatment of amyotrophic lateral sclerosis |
| 08/19/2004 | WO2004069173A2 Methods for modulating an inflammatory response |
| 08/19/2004 | WO2004069172A2 Multilineage-inducible cells and uses thereof |
| 08/19/2004 | WO2004069171A2 Novel compounds for the treatment of sickle cell disease |
| 08/19/2004 | WO2004069169A2 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
| 08/19/2004 | WO2004069168A2 Novel antiherpes drug combinations |
| 08/19/2004 | WO2004069167A2 Method and compositions for treating male infertility |
| 08/19/2004 | WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | WO2004069165A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/19/2004 | WO2004069164A2 Wireless blood glucose monitoring system |
| 08/19/2004 | WO2004069160A2 Chemical compounds |
| 08/19/2004 | WO2004069159A2 Vitamin receptor binding drug delivery conjugates |
| 08/19/2004 | WO2004069158A2 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/19/2004 | WO2004069157A2 Combinational use of long-acting and short-acting anti-histamines for ocular allergies |
| 08/19/2004 | WO2004069156A2 Inactivated probiotic bacteria and methods of use thereof |
| 08/19/2004 | WO2004069154A2 Method for detecting remote homologues and novel kinases identified with the method |
| 08/19/2004 | WO2004069153A2 Apparatus, system and method for generating bubbles on demand |
| 08/19/2004 | WO2004069148A2 Snornai-small nucleolar rna degradation by rna interference in trypanosomatids |
| 08/19/2004 | WO2004069147A2 System for enhanced chemical debridement |
| 08/19/2004 | WO2004069146A2 L-dopa amide derivatives and uses thereof |
| 08/19/2004 | WO2004069145A2 Anticancer compounds, process for their preparation and pharmaceutical compositions containing them |
| 08/19/2004 | WO2004069144A2 Method for decreasing nicotine and other substance use in humans |
| 08/19/2004 | WO2004069137A2 Use of polyamino and/or polyammonium-polysiloxane copolymers |
| 08/19/2004 | WO2004062571A3 Substantially pure cilostazol and processes for making same |
| 08/19/2004 | WO2004058180A3 Intraoral calculus dissolving gel composition |
| 08/19/2004 | WO2004050026A3 Compositions and methods for treating prostate cancer |
| 08/19/2004 | WO2004043388A3 Chewing gum with encapsulated stain removing agent |
| 08/19/2004 | WO2004041195A3 Pharmaceutical formulations targeting specific regions of the gastrointestinal tract |
| 08/19/2004 | WO2004026227A3 A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS |
| 08/19/2004 | WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases |
| 08/19/2004 | WO2004021980B1 Compositions and methods for treating niddm and other conditions and disorders associated with ampk regulation |
| 08/19/2004 | WO2004017909A3 Methods of reducing ischemic injury |
| 08/19/2004 | WO2004010923A3 Delivering compounds to the brain by modifying properties of the bbb and cerebral circulation |
| 08/19/2004 | US20040162410 Thrombosis therapy; anticoagulants |
| 08/19/2004 | US20040162268 Extracted portion of psyllium seed with a binder and/or edible acid; polysaccharide component comprising xylose and arabinose in given ratio; specified mean particle size distribution; use for therapy of gastrointestinal disorders, as laxative |
| 08/19/2004 | US20040162267 Compositions comprising a polysaccharide component and one or more coating layers |
| 08/19/2004 | US20040162266 Compositions comprising a defined polysaccharide component |